Bruce N. Jacobs
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $10.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,500320,492 held (−0%) | $110.54 | $166K | +1.7% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,700318,792 held (−1%) | $111.57 | $190K | +0.7% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,100317,692 held (−0%) | $112.79 | $124K | -0.3% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 4,110313,582 held (−1%) | $114.19 | $469K | -1.6% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 51,375262,207 held (−16%) | $114.77 | $5.9M | -2.1% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7,971254,236 held (−3%) | $115.82 | $923K | -3.0% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 6,153248,083 held (−2%) | $116.99 | $720K | -3.9% |
| Jul 2SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,200244,883 held (−1%) | $117.70 | $377K | -4.5% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 2,039243,020 held (−1%) | $87.75 | $179K | +28.1% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 1,424241,596 held (−1%) | $88.50 | $126K | +27.0% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 4,113237,483 held (−2%) | $89.66 | $369K | +25.4% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 492236,991 held (−0%) | $84.00 | $41K | +33.8% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 2,519234,472 held (−1%) | $85.04 | $214K | +32.2% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 1,437233,035 held (−1%) | $85.78 | $123K | +31.0% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 447232,588 held (−0%) | $86.62 | $39K | +29.8% |
- Sell
CFO Bruce N. Jacobs sold $166K of KYMR at $110.54 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Bruce N. Jacobs sold $190K of KYMR at $111.57 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Bruce N. Jacobs sold $124K of KYMR at $112.79 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Bruce N. Jacobs sold $469K of KYMR at $114.19 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Bruce N. Jacobs sold $5.9M of KYMR at $114.77 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Bruce N. Jacobs sold $923K of KYMR at $115.82 — pre-scheduled 10b5-1 plan sale.